58 related articles for article (PubMed ID: 11244964)
1. [Detection of MDM 2 and p 53 genes in rhabdomyosarcoma by in situ hybridization].
Lai R; Wang Z; Zhe X
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):127-9. PubMed ID: 11244964
[TBL] [Abstract][Full Text] [Related]
2. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
[TBL] [Abstract][Full Text] [Related]
3. [The correlation between expression of oncogene protein products p53, p21, p185 and cell differentiation and prognosis in rhabdomyosarcoma].
Lai R; Luo Z; An J
Zhonghua Bing Li Xue Za Zhi; 1997 Feb; 26(1):35-7. PubMed ID: 10072848
[TBL] [Abstract][Full Text] [Related]
4. [Detection of p53 and MDM2 gene expression in osteosarcoma with biotin-labelled in situ].
Wang X; Wang S; Feng C
Zhonghua Wai Ke Za Zhi; 1997 Mar; 35(3):178-80. PubMed ID: 10374529
[TBL] [Abstract][Full Text] [Related]
5. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.
Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC
Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230
[TBL] [Abstract][Full Text] [Related]
6. [Alterations of MDM2 and p53 genes in bone tumors].
Zhou X; Gao L; Zhe X
Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):270-2. PubMed ID: 10374333
[TBL] [Abstract][Full Text] [Related]
7. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
[TBL] [Abstract][Full Text] [Related]
8. Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis.
Gustafsson B; Christenson B; Hjalmar V; Winiarski J
Med Pediatr Oncol; 2000 Feb; 34(2):117-24. PubMed ID: 10657873
[TBL] [Abstract][Full Text] [Related]
9. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of mdm2 and p53 expression in orbital rhabdomyosarcoma].
Xu XL; Li B; Sun XL; Li LQ
Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):755-9. PubMed ID: 15634483
[TBL] [Abstract][Full Text] [Related]
11. Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines.
Bartel F; Taylor AC; Taubert H; Harris LC
Oncol Res; 2001; 12(11-12):451-7. PubMed ID: 11939408
[TBL] [Abstract][Full Text] [Related]
12. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
14. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
Zietz C; Rössle M; Haas C; Sendelhofert A; Hirschmann A; Stürzl M; Löhrs U
Am J Pathol; 1998 Nov; 153(5):1425-33. PubMed ID: 9811333
[TBL] [Abstract][Full Text] [Related]
15. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.
Jacob AG; O'Brien D; Singh RK; Comiskey DF; Littleton RM; Mohammad F; Gladman JT; Widmann MC; Jeyaraj SC; Bolinger C; Anderson JR; Barkauskas DA; Boris-Lawrie K; Chandler DS
Neoplasia; 2013 Sep; 15(9):1049-63. PubMed ID: 24027430
[TBL] [Abstract][Full Text] [Related]
16. Strong correlation of basement membrane degradation with p53 inactivation and/or MDM2 overexpression in superficial urothelial carcinomas.
Ozdemir E; Kakehi Y; Okuno H; Habuchi T; Okada Y; Yoshida O
J Urol; 1997 Jul; 158(1):206-11. PubMed ID: 9186361
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.
Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C
Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770
[TBL] [Abstract][Full Text] [Related]
18. [Point mutations of N-ras oncogene and abnormal expression of rasp21, p53 proteins in orbital rhabdomyosarcoma].
Zhang H; Song G; Zhang S; Chang J; Zhang W; Yu H
Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):267-9, 16. PubMed ID: 11853610
[TBL] [Abstract][Full Text] [Related]
19. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675
[TBL] [Abstract][Full Text] [Related]
20. GLI1 expression is an important prognostic factor that contributes to the poor prognosis of rhabdomyosarcoma.
Wang Y; Sun C; Jiang J; Xie Y; Li B; Cui X; Chen Y; Liu C; Li F
Histol Histopathol; 2016 Mar; 31(3):329-37. PubMed ID: 26544916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
